EP1137669B1 - Storage-stable composition comprising squaric acid activated carrier usable for immobilisation of compounds containing amine groups - Google Patents
Storage-stable composition comprising squaric acid activated carrier usable for immobilisation of compounds containing amine groups Download PDFInfo
- Publication number
- EP1137669B1 EP1137669B1 EP99970668A EP99970668A EP1137669B1 EP 1137669 B1 EP1137669 B1 EP 1137669B1 EP 99970668 A EP99970668 A EP 99970668A EP 99970668 A EP99970668 A EP 99970668A EP 1137669 B1 EP1137669 B1 EP 1137669B1
- Authority
- EP
- European Patent Office
- Prior art keywords
- composition
- carrier
- activated
- matrix
- groups
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 30
- 150000001875 compounds Chemical class 0.000 title claims abstract description 17
- PWEBUXCTKOWPCW-UHFFFAOYSA-N squaric acid Chemical compound OC1=C(O)C(=O)C1=O PWEBUXCTKOWPCW-UHFFFAOYSA-N 0.000 title claims abstract description 14
- 125000003277 amino group Chemical group 0.000 title claims abstract description 13
- 239000012736 aqueous medium Substances 0.000 claims abstract description 20
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 38
- 239000011159 matrix material Substances 0.000 claims description 21
- 239000002609 medium Substances 0.000 claims description 15
- 238000000034 method Methods 0.000 claims description 15
- 239000011324 bead Substances 0.000 claims description 14
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 12
- 125000002924 primary amino group Chemical class [H]N([H])* 0.000 claims description 9
- 125000000467 secondary amino group Chemical group [H]N([*:1])[*:2] 0.000 claims description 9
- 229910052760 oxygen Inorganic materials 0.000 claims description 6
- 230000000269 nucleophilic effect Effects 0.000 claims description 5
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 4
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 claims description 4
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 claims description 4
- BTANRVKWQNVYAZ-UHFFFAOYSA-N butan-2-ol Chemical compound CCC(C)O BTANRVKWQNVYAZ-UHFFFAOYSA-N 0.000 claims description 4
- 230000001747 exhibiting effect Effects 0.000 claims description 4
- 229910052717 sulfur Inorganic materials 0.000 claims description 4
- 230000001588 bifunctional effect Effects 0.000 claims description 3
- 238000001704 evaporation Methods 0.000 claims description 3
- 230000008020 evaporation Effects 0.000 claims description 3
- 238000005406 washing Methods 0.000 claims description 3
- 229960004592 isopropanol Drugs 0.000 claims description 2
- 125000000962 organic group Chemical group 0.000 claims description 2
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 claims description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims 3
- 238000004519 manufacturing process Methods 0.000 claims 1
- 239000002904 solvent Substances 0.000 claims 1
- 239000003446 ligand Substances 0.000 abstract description 5
- PWEBUXCTKOWPCW-UHFFFAOYSA-L squarate Chemical compound [O-]C1=C([O-])C(=O)C1=O PWEBUXCTKOWPCW-UHFFFAOYSA-L 0.000 description 12
- 239000000543 intermediate Substances 0.000 description 11
- 239000000969 carrier Substances 0.000 description 9
- 238000006243 chemical reaction Methods 0.000 description 9
- -1 monoliths Substances 0.000 description 8
- 238000001994 activation Methods 0.000 description 7
- 150000001412 amines Chemical class 0.000 description 7
- WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 description 6
- 239000007788 liquid Substances 0.000 description 6
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 5
- 230000004913 activation Effects 0.000 description 5
- 239000000872 buffer Substances 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 229920000642 polymer Polymers 0.000 description 5
- BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 description 4
- 230000008878 coupling Effects 0.000 description 4
- 238000010168 coupling process Methods 0.000 description 4
- 238000005859 coupling reaction Methods 0.000 description 4
- 238000004128 high performance liquid chromatography Methods 0.000 description 4
- 230000009257 reactivity Effects 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
- 239000004593 Epoxy Substances 0.000 description 3
- 102000004142 Trypsin Human genes 0.000 description 3
- 108090000631 Trypsin Proteins 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 150000001720 carbohydrates Chemical class 0.000 description 3
- 230000007062 hydrolysis Effects 0.000 description 3
- 238000006460 hydrolysis reaction Methods 0.000 description 3
- 239000003960 organic solvent Substances 0.000 description 3
- 239000012588 trypsin Substances 0.000 description 3
- KAKZBPTYRLMSJV-UHFFFAOYSA-N Butadiene Chemical group C=CC=C KAKZBPTYRLMSJV-UHFFFAOYSA-N 0.000 description 2
- 239000007832 Na2SO4 Substances 0.000 description 2
- 239000012506 Sephacryl® Substances 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 2
- 239000007983 Tris buffer Substances 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 229910021529 ammonia Inorganic materials 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 235000019445 benzyl alcohol Nutrition 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- 230000003100 immobilizing effect Effects 0.000 description 2
- 239000007791 liquid phase Substances 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 230000000813 microbial effect Effects 0.000 description 2
- 150000002894 organic compounds Chemical class 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 230000000717 retained effect Effects 0.000 description 2
- 229910052938 sodium sulfate Inorganic materials 0.000 description 2
- 238000013112 stability test Methods 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- 238000005809 transesterification reaction Methods 0.000 description 2
- RAXXELZNTBOGNW-UHFFFAOYSA-N 1H-imidazole Chemical group C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004856 Lectins Human genes 0.000 description 1
- 108090001090 Lectins Proteins 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 102000001708 Protein Isoforms Human genes 0.000 description 1
- 108010029485 Protein Isoforms Proteins 0.000 description 1
- 229920001218 Pullulan Polymers 0.000 description 1
- 239000004373 Pullulan Substances 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 239000005864 Sulphur Substances 0.000 description 1
- 239000008351 acetate buffer Substances 0.000 description 1
- 125000003158 alcohol group Chemical group 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 125000005907 alkyl ester group Chemical group 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 238000005576 amination reaction Methods 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 150000001555 benzenes Chemical class 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 125000005518 carboxamido group Chemical group 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 235000010980 cellulose Nutrition 0.000 description 1
- 239000013065 commercial product Substances 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- ATDGTVJJHBUTRL-UHFFFAOYSA-N cyanogen bromide Chemical compound BrC#N ATDGTVJJHBUTRL-UHFFFAOYSA-N 0.000 description 1
- 125000000753 cycloalkyl group Chemical group 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 230000000368 destabilizing effect Effects 0.000 description 1
- 150000005690 diesters Chemical class 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 125000003700 epoxy group Chemical group 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 125000001183 hydrocarbyl group Chemical group 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- 230000005660 hydrophilic surface Effects 0.000 description 1
- 229920001600 hydrophobic polymer Polymers 0.000 description 1
- 125000004356 hydroxy functional group Chemical group O* 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 239000002523 lectin Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- OJURWUUOVGOHJZ-UHFFFAOYSA-N methyl 2-[(2-acetyloxyphenyl)methyl-[2-[(2-acetyloxyphenyl)methyl-(2-methoxy-2-oxoethyl)amino]ethyl]amino]acetate Chemical compound C=1C=CC=C(OC(C)=O)C=1CN(CC(=O)OC)CCN(CC(=O)OC)CC1=CC=CC=C1OC(C)=O OJURWUUOVGOHJZ-UHFFFAOYSA-N 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 229910000069 nitrogen hydride Inorganic materials 0.000 description 1
- 150000007523 nucleic acids Chemical group 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 125000004430 oxygen atom Chemical group O* 0.000 description 1
- RVTZCBVAJQQJTK-UHFFFAOYSA-N oxygen(2-);zirconium(4+) Chemical compound [O-2].[O-2].[Zr+4] RVTZCBVAJQQJTK-UHFFFAOYSA-N 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 235000019423 pullulan Nutrition 0.000 description 1
- 239000012429 reaction media Substances 0.000 description 1
- 239000012048 reactive intermediate Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 238000010532 solid phase synthesis reaction Methods 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 125000004434 sulfur atom Chemical group 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 150000003568 thioethers Chemical class 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 229910001928 zirconium oxide Inorganic materials 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K17/00—Carrier-bound or immobilised peptides; Preparation thereof
- C07K17/02—Peptides being immobilised on, or in, an organic carrier
- C07K17/06—Peptides being immobilised on, or in, an organic carrier attached to the carrier via a bridging agent
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
- C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
- C12N11/06—Enzymes or microbial cells immobilised on or in an organic carrier attached to the carrier via a bridging agent
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54393—Improving reaction conditions or stability, e.g. by coating or irradiation of surface, by reduction of non-specific binding, by promotion of specific binding
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/81—Packaged device or kit
Definitions
- Nucleophilic compounds that are contemplated in the context of the invention typically contain a primary and/or a secondary amine group, for instance proteins or other compounds exhibiting peptide structure or other biomolecules and other organic compounds exhibiting this type of amine groups.
- the pH of the aqueous medium may be in the range 5-9.
- Standard buffer systems that do not adversely affect the stability may be used, e.g. 0.3 M borate buffer.
- Amine buffers, in particular adjusted to pH below 1 minus their pKa should be avoided.
- Polymer beads (Sephacryl S-200, Amersham Pharmacia Biotech AB, Uppsala, Sweden) were amine functionalized in the following way.
- the beads were washed with ethanol 99.5 % followed with 20 % ethanol.
- the activated beads were divided in 10 ml samples slurried in 20% ethanol and stored at 2-8°C.
- the storage medium used in the examples is 20% ethanol in water, temperature 2-8°C
- Stability tests on the intermediates in the storage mode according to the present invention were made by taking samples of the intermediates at irregular intervals during 66 weeks (more precisely at 1, 6, 10, 12, 18, 26, 40 and 66 weeks).
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Medicinal Chemistry (AREA)
- General Engineering & Computer Science (AREA)
- Pathology (AREA)
- Cell Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Peptides Or Proteins (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Medicinal Preparation (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Other Resins Obtained By Reactions Not Involving Carbon-To-Carbon Unsaturated Bonds (AREA)
- Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
Abstract
Description
- The present invention relates to storage stable, activated carrier in the form of matrices including surfaces. In particular it relates to such matrices suitable as carrier to which compounds containing an amine group may be covalently bound.
- The invention also relates to a kit comprising such activated carrier, the kit being shippable to customers by virtue of the long term stability of said carrier.
- In the context of this description of the invention the words carrier/carriers, matrix/matrices and medium/media are used interchangeable, if not otherwise said.
- The immobilization of biomolecules on various carriers finds great utility in research and industry, and many methods have been disclosed in the literature. These methods comprise an activation of a carrier, e.g. a matrix in the form of a gel, a surface of a polymer bead etc. The activation process generally comprises subjecting the carrier to a reactive agent that reacts with ―OH groups or amine groups on the carrier, thereby, either directly or subsequent to further steps, forming intermediate reactive structures/sites. These structures may then be reacted with the compound in question, thereby immobilizing the compound.
- Illustrative examples of such methods are the CNBr method, and epoxy activation. The activated intermediates obtained by these methods must be freeze dried in order to be shippable to customers. Freeze drying is fairly complicated and in addition require processing at the customer before the freeze dried intermediates can be used.
- These and other activation and immobilization methods are described in "Immobilized affinity ligand techniques" by G.T. Hermanson, Academic Press, 1992.
- In WO 95/15983 (Glüsenkamp et al) there is disclosed a process for immobilizing biomolecules and affinity ligands on carriers. This process comprises reacting an aminated polymer carrier with a bifunctional electrophilic squaric acid derivative as activating agents to form an activated intermediate (activated matrix or activated media or activated carrier), and coupling a biomolecule to the activated carrier.
- For most of the above-mentioned activation processes it has been commonly known that the activated carriers are relatively unstable towards hydrolysis. Remembering that commercially available activated carrier media should have as long shelf time as possible, for instance from one up to several months, it is no surprise that commercial products comprising activated matrices typically have been sold in form of lyophilized compositions. For squarate activated carrier media we are not aware of any commercial products differing from what has been said above. When looking into the scientific literature it appears that most synthetic routes in which squarate activated material are obtained typically end up in crystallised and/or dried material. In the alternative the activated material is used more or less directly upon synthesis. See for instance Kamath et al., Glycoconjugate J. 13 (1996) 315-319; and Ola Blixt, Thesis: Enzymatic solid phase synthesis of carbohydrates, Swedish University of Agricultural Sciences, Uppsala, Sweden (1999) (see in particular page 50); DE 4341524 (Glüsenkamp et al); and DE 19624990 (Glüsenkamp et al). An investigation of the hydrolysis of soluble squarate activated materials (monoamides) has been published (Glüsenkamp et al., Z. Naturforsch. 46c (1991) 498-501). The storage of squarate activated aminated matrices moistured with methanol or in ethanol atmosphere has been described in the experimental part of WO 9515983 (Glüsenkamp et al). The reactivity is expected to be retained during these storing conditions because reaction with methanol and ethanol, respectively, will only mean a transesterification retaining the ester status of the activated group and thus also maintaining its reactivity.
- It would be advantageous to provide a commercial product in form of an activated carrier comprising reactive squaryl groups said activated carrier being dispensed in aqueous media and having a shelf life of from 1-2 months up to several months without showing any significant loss in activity. This is in particular true in case the use is for immobilising water-soluble compounds to the activated medium, for instance amine-containing biomolecules such as proteins. The aqueous media is typically an aqueous liquid.
- It would also be advantageous in case such storage stable compositions would be resistent towards microbial growth.
- Other publications connected to squarate activated materials are Tietze et al., Chem. Ber. 124(5) (1991) 1215-1221; Tietze et al., Bioconjugate Chem 2 (1991) 148-153; Hällgren et al., J. Carbohydrate Chem. 14(4&5) (1995) 453-46; Ausanneau et al., Bioorganic & Medicinal Chemistry 4 (1996) 2003-2010; and Pozsgay et al., J. Org. Chem. 62 (1997) 2832-2846.
- The object of the present invention is therefore to provide a storage stable activated carrier comprising reactive squaryl groups, said carrier being dispensed in an aqueous medium for use in the immobilization of nucleophilic compounds, typically amine containing compounds. The activated medium should be stable during storage and/or resistent against bacterial growth over extended periods of time.
- For the purpose of the invention the term "activated medium" or "activated carrier" or "activated matrix" mean a carrier to be used as a carrier for a nucleophilic compound. Said carrier has been provided with reactive squaryl groups enabling easy coupling of said compound to said carrier. The activated carrier should be regarded as an intermediate in the process of making immobilized forms of said compounds.
- Nucleophilic compounds that are contemplated in the context of the invention typically contain a primary and/or a secondary amine group, for instance proteins or other compounds exhibiting peptide structure or other biomolecules and other organic compounds exhibiting this type of amine groups.
- The inventor has now surprisingly discovered that a carrier as defined above comprising amine groups activated with an electrophilic squaric acid derivative may be stable in aqueous media. Unexpectedly it has been recognized that the rate of hydrolysis of reactive squarate groups bound to carriers is sufficiently slow for enabling storage of the activated carriers in aqueous media.
- Thus, in accordance with the present invention there is provided a storage stable composition comprising a carrier as defined above and usable for the immobilization of nucleophilic compounds. The carrier comprises primary or secondary amino groups that have been activated to carry reactive squaric acid derived groups linked to said primary or secondary amine sites on said carrier, said carrier being in contact with an aqueous medium, e.g. an aqueous liquid.
- In a second aspect of the invention there is provided a method of preparing such a composition. This method is defined in claim 9.
- Furthermore, in accordance with the invention there is provided a kit for storing the composition over extended periods of time, this being defined in
claim 10. - The composition according to the present invention is stable for an extended period of time as defined above, for instance for a week, a month or even longer periods of time, such as two, three or more months.
- Preferred embodiments are defined in the dependent claims.
- The squaric acid derivatives useful for making the activated carriers may be selected among bifunctional electrophilic squaric acid derivatives, such as dialkoxyesters (e.g. dimethylester, diethylester, dibutylester and also corresponding mixed diester (squarates)), dihalides and diimidazolides. Other reactive derivatives may also be used. The activation reaction is normally run in inert media. See Glüsenkamp WO9515983. In case the reactive group formed on the carrier is too reactive to be stored in the contemplated aqueous media, it may be easily transformed to a group of lower reactivity. For instance, in case a squaric acid dihalide is used to prepare the activated carriers, the formed monohalide group may be transformed to the corresponding ester function, for instance by running the reaction in the presence of an alcohol.
-
- P represents a matrix (carrier) containing primary and/or secondary amine groups binding to the squaric acid derived structure (squaryl group, e.g. squarate structure) which in turn constitutes the reactive group in the formula above. There are often several reactive squaric acid derived groups (e.g. squarate groups) on one and the same matrix P.
- A and B independently of each other can be O or S;
- X can be O or S; and
- R may represent an inert organic group that together with X and the squaryl group forms an electrophilic structure.
- R is, for instance, a C1 to C30 hydrocarbon group comprising one or more straight, branched or cyclic hydrocarbon chains that may be broken at one or more locations by a thioether sulphur or an ether oxygen and/or substituted with one or more R'O- groups where R' is hydrogen and/or C1 to C6 alkyl or corresponding sulphur analogues (R'S-). The preferred Rs are C1 to C6 alkyl, such as methyl, ethyl, n-propyl, isopropyl, and possibly also isoforms of butyl. Preferably there are at most one O or S atom on each carbon atom in R.
- R may also be an imidazolide group or another group resulting in the squarate structure in the general formula being a reactive electrophilic squarate group on the carrier. In this case the stability of the activated carrier shall be comparable to the stability of the squaric acid mono amide mono alkyl ester groups defined above (R = alkyl).
- By the term "inert" is meant that R does not contain any group that adversely affect the reactivity of the activated squaryl group shown. Destabilizing groups in R may for instance be primary and secondary amines.
- By the term "stable" is meant that the ability to react with primary and secondary amines is retained for a prolonged time without being significantly or irreproducibly decreased. This in turns means that the activated intermediate can be stable even if the activated intermediate participate in transesterifications with alcohol groups present in the storage media, the carrier or the inert group R.
- As carriers to be activated with squaric acid derivatives defined above, matrices exhibiting primary and/or secondary amine groups can be used.
- The term "matrix" is to be understood to encompass any physical form such as particles, monoliths, fibers, membranes, tube walls, capillaries, surfaces etc. The matrix may be porous or non-porous and soluble, insoluble or insolubilizable in aqueous media or other liquids.
- In the preferred modes of the invention the matrix is based on a polymer that exposes a hydrophilic surface to the aqueous media used, i.e. expose hydroxy (-OH), carboxy (-COOH), carboxamido (-CONH2, possibly in N- substituted forms), amino (-NH2, possibly in substituted form), oligo- or polyethylenoxy groups on their external and, if present, also on internal surfaces. Typically the matrix is of the same kind as those normally used as chromatographic matrices. The polymer may, for instance, be based on polysaccharides, such as dextran, starch, cellulose, pullulan, agarose etc, which if necessary have been crosslinked, for instance with bisepoxides, epihalohydrins, 1,2,3-trihalo substituted lower hydrocarbons, to provide a suitable porosity and rigidity. The matrix may also be based on synthetic polymers, such as polyvinyl alcohol, poly hydroxyalkyl acrylates, poly hydroxyalkyl methacrylates, poly acrylamides, polymethacrylamides etc. In case of hydrophobic polymers, such as those based on divinyl and monovinyl substituted benzenes, the surfaces of the matrix are often hydrophilized to expose hydrophilic groups as defined above to a surrounding aqueous liquid.
- The matrices may also be of inorganic nature, e.g. silica, zirconium oxide etc.
- If the matrices as such do not exhibit amine functionality they may be derivatized by methods known by the man skilled in the art to do so.
- The activating method is fully described in the referenced WO-publication, and will not be discussed herein.
- The storage medium for the intermediates in question is aqueous, typically in form of an aqueous liquid. It preferably comprises an antibacterially active component. This component preferably is selected form organic solvents suitably miscible with water.
- A preferred class of components is alcohols, in particular alkanols, such as methanol, ethanol, propanol, iso-propanol, butanol, sec-butanol, tert-butanol. The most preferred alcohol is ethanol.
- The amount of the antibacterial component needed is an amount sufficient for preventing bacterial or microbial growth in the composition.
- The composition of the aqueous medium may comprise water in an amount of 5-100 %, preferably 20-95 %, more preferably 40-85 %. The amount of organic solvent suitably miscible with water is in the interval 5-95 %, preferably 5-80 %, more preferably 10-60 % such as 25-60. Volume-% (v/v) is contemplated. The organic solvent is preferably a water-miscible alcohol.
- The pH of the aqueous medium may be in the range 5-9. Standard buffer systems that do not adversely affect the stability may be used, e.g. 0.3 M borate buffer. Amine buffers, in particular adjusted to pH below 1 minus their pKa should be avoided.
- When being used the activated carrier is contacted with an organic compound containing an amine group under conditions permitting binding of the amine compound to the carrier via a newly formed squarate amide structure. The compound containing the amine function is preferably a bioorganic molecule. Typically the amine compound is a member of a so-called affinity pair. Examples of affinity pairs are antigen/hapten - antibody, carbohydrate structure - lectin, complementary nucleic acid sequences and any other native or synthetic ligand-receptor pair in which the ligand and receptor are able to cling to each other via affinity. One special class of affinity pairs has biological origin. They are consequently called bioaffinity pairs.
-
- In scheme A, RNH2 is the compound to be immobilized to the matrix. The scheme is focusing on one kind of introduced amino groups. The reaction will in principle be the same for the other amino groups.
- Figure 1 gives a graph showing the long-term stability of a composition according to the invention. The amino acid analysis data shown correspond to coupling yields of 75-85 %. We have immobilized other ligands with similar or higher yields.
- Polymer beads (Sephacryl S-200, Amersham Pharmacia Biotech AB, Uppsala, Sweden) were amine functionalized in the following way.
- Epoxy activated beads were washed with water and drained, and then added to a reaction vessel and an equal volume of 1 M NH3 was added to the vessel. The vessel was sealed and circle shaken in a water bath at 50°C for 23 h. The beads were washed with water (>10 x gel volume) and stored in 20% ethanol in water at +2 - +8°C.
- After amination the beads will contain different amino groups -CH2CHOHCH2NH2 (obtained by reaction of ammonia with epoxy groups), -NHCOCH2CHNH2 (obtained by reaction of ammonia with acrylamido groups and corresponding crosslinking groups obtained via further reaction with epoxy and acrylamido groups.
- The amine functionalised Sephacryl (100 ml, from Example 1) stored in 20% EtOH, was washed with absolute ethanol (10 x 1 gel volumes). The beads were added to a flask with screw cap. An equal volume of absolute ethanol was added followed with benzyl alcohol (ca 250 µl/50 ml ethanol) and the squarate (ca 1.5-2 equivalents compared to the amine contents of the beads). The reagents were mixed and a small sample of the liquid phase, used as reference for HPLC, was taken out immediately. The flask was shaken in a water-bath at 20-60 °C. The progress of the reaction was followed by HPLC by taking out small samples of the liquid phase, after regular intervals, dilute 50 times with EtOH (30 µl in 1.5 ml) and analyse on a Shimadzu HPLC. Benzyl alcohol was used as an internal standard in the HPLC analysis. The substitution degree was assumed to be approximately equal to the consumed amount of the squarate reagent.
- The beads were washed with ethanol 99.5 % followed with 20 % ethanol. The activated beads were divided in 10 ml samples slurried in 20% ethanol and stored at 2-8°C.
- The activated beads, stored in 20% EtOH, were washed with water (ca 5 x 1 gel volume, gv), followed with a borate buffer 0.3M borate 1.5 M Na2SO4, pH 9. The enzyme solution was made by dissolving 100 mg Porcine trypsin in
ca 10 ml 0.5 M Na2SO4 and 0.3 M borate buffer pH 9 which was added to the beads The mixture was shaken at room temperature for 6 hrs. The beads were washed with tris buffer (0.1 M, 0.5 M NaCl, pH 8) 4x1 gel volumes. Followed, alternatively four times with tris and acetate buffer (0.1 M, pH 5), and finally with water five times. Stored in 20% EtOH. - Stability tests on the intermediates in the storage mode according to the present invention (the storage medium used in the examples is 20% ethanol in water, temperature 2-8°C) were made by taking samples of the intermediates at irregular intervals during 66 weeks (more precisely at 1, 6, 10, 12, 18, 26, 40 and 66 weeks).
- These samples were used for immobilization of porcine trypsin on the matrix according to example 3 The substitution degree was investigated by amino acid analysis.
- Figure 1 shows the results from the storage test. From this figure it can be concluded that within the experimental errors, the intermediates are stable in the aqueous storage medium over an extended period of time, i.e. at least about 66 weeks.
- The composition according to the invention is suitably prepared by replacing the liquid reaction medium from the activated carrier medium, for instance by washing, with the aqueous medium that ultimately will be used for storing the composition.
- The composition is delivered to the customer as a kit comprising a storage container containing the composition, i.e. the activated medium in contact with the aqueous medium. Such storage means can comprise bottles, ampoules, flasks, and other closed vessels not permitting evaporation. In case of carrier media in the form of open surfaces (e.g. wells of a microtiter plate), and monolithic porous and nonporous matrices, strips and the like, the medium itself may function as the storage means, provided there is an appropriate cover means preventing evaporation from the activated surface.
Claims (11)
- A storage stable composition comprising a carrier exhibiting primary and secondary amine groups and usable for the immobilization of amine group containing compounds, said carrier medium being activated to exhibit electrophilic squaric acid derived groups linked to said medium, said carrier medium being in contact with an aqueous medium, said composition being comprised in a closed vessel not permitting evaporation of said aqueous medium.
- The composition of claim 1, wherein said activated carrier medium is represented by the formula
wherein• P represents a carrier;• A and B independently of each other can be O or S;• X can be O or S; and• R represents an inert organic group that together with X and the squaryl group forms an electrophilic structure. - The composition of anyone of claims 1-2, further comprising an antibacterially active component.
- The composition of claim 3, wherein the antibacterially active component is a solvent miscible with water, preferably an alcohol, in particular methanol, ethanol, propanol, iso-propanol, butanol, sec-butanol, tert-butanol, or ethylene glycol.
- The composition of anyone claims 1- 4, wherein said aqueous medium comprises water in an amount of 5-100 %, preferably 20-95 %, more preferably 40-85 %, and/or an alcohol in an amount of 95-5 %, preferably 80-5 %, more preferably 60-25 %.
- The composition of anyone claims 1- 4, wherein said aqueous medium comprises an alcohol in an amount of 5-95 %, preferably 5-80 %, more preferably 10-60 %, such as 25-60%.
- The composition of any one of claims 1-6, which is stable for at least 1 week, preferably for at least 66 weeks.
- The composition of any one of claims 1-7, wherein said carrier is in the form of beads.
- The composition of any one of claims 1-8, wherein the pH of the aqueous medium is 5-9.
- A method of making a storage stable composition comprising a matrix carrying reactive electrophilic squaryl groups, said method comprisingi) reacting a matrix comprising primary and/or secondary amine groups with a bifunctional nucleophilic squaric acid derivative thereby introducing squaryl groups on the matrix to give an activated matrixii) washing the activated matrix with an aqueous medium; andiii) storing said activated matrix in said aqueous washing medium for at least a week.
- A kit comprising a means for storing a composition as claimed in any of claims 1-9, and such a composition contained in said storing means.
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9803565 | 1998-10-16 | ||
| SE9803565A SE9803565D0 (en) | 1998-10-16 | 1998-10-16 | Media and kit containing said media |
| SE9803588A SE9803588D0 (en) | 1998-10-19 | 1998-10-19 | Medium and kit containing said medium |
| SE9803588 | 1998-10-19 | ||
| PCT/SE1999/001861 WO2000023478A1 (en) | 1998-10-16 | 1999-10-14 | Squaric acid activated carrier usable for immobilisation of compounds containing amine groups |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EP1137669A1 EP1137669A1 (en) | 2001-10-04 |
| EP1137669B1 true EP1137669B1 (en) | 2006-09-20 |
Family
ID=26663419
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP99970668A Expired - Lifetime EP1137669B1 (en) | 1998-10-16 | 1999-10-14 | Storage-stable composition comprising squaric acid activated carrier usable for immobilisation of compounds containing amine groups |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US6656876B1 (en) |
| EP (1) | EP1137669B1 (en) |
| JP (1) | JP2002527526A (en) |
| AT (1) | ATE340192T1 (en) |
| AU (1) | AU772324B2 (en) |
| CA (1) | CA2346871A1 (en) |
| DE (1) | DE69933310T2 (en) |
| ES (1) | ES2272099T3 (en) |
| WO (1) | WO2000023478A1 (en) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10013794A1 (en) * | 2000-03-15 | 2001-10-11 | Gluesenkamp Karl Heinz | Production, stabilization and application of a new type of chemically activated surface |
| SE520256C2 (en) * | 2001-10-25 | 2003-06-17 | Lundonia Biotech Ab | Biomolekylkvadratsyramonoamidkopplingsreagensintermediär |
| EP1476753B1 (en) * | 2001-11-14 | 2013-08-14 | Luminex Corporation | Functionalized compositions for improved immobilization |
| US20090233142A2 (en) * | 2004-04-30 | 2009-09-17 | Sumitomo Chemical Company, Limited | Polymer having oxocarbon group, and use thereof |
| JP4752318B2 (en) * | 2004-04-30 | 2011-08-17 | 住友化学株式会社 | Polymer having oxocarbon group and use thereof |
| JP2008509226A (en) * | 2004-05-24 | 2008-03-27 | ジェンボールト コーポレイション | Stable protein storage and stable nucleic acid storage in recoverable format |
| JP4988578B2 (en) * | 2004-10-12 | 2012-08-01 | ルミネックス コーポレーション | Method for changing the surface properties of microspheres |
| US8138231B2 (en) * | 2007-10-29 | 2012-03-20 | Sumitomo Chemical Company, Limited | Polymer having oxycarbon group, and use thereof |
| CN102177237B (en) * | 2008-09-12 | 2013-10-30 | 金沃特公司 | Matrices and media for storage and stabilization of biomolecules |
| WO2016058056A1 (en) | 2014-10-16 | 2016-04-21 | The University Of Melbourne | Novel imaging composition and uses thereof |
| KR20170121746A (en) | 2015-04-13 | 2017-11-02 | 후지필름 가부시키가이샤 | Method of producing short-chain peptide immobilization carrier and short-chain peptide immobilization carrier |
| CN111495328B (en) * | 2020-04-24 | 2022-05-17 | 太原理工大学 | Ammonia modification method of calcium squarate and application of ammonia modification method in efficient separation of ethylene and ethane |
| CN114507722A (en) * | 2020-11-16 | 2022-05-17 | 深圳市真迈生物科技有限公司 | Compound modified chip and preparation method and application thereof |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CS148930B1 (en) * | 1970-09-16 | 1973-05-24 | ||
| US5028535A (en) * | 1989-01-10 | 1991-07-02 | Biosite Diagnostics, Inc. | Threshold ligand-receptor assay |
| SE500248C2 (en) * | 1992-12-03 | 1994-05-24 | Eka Nobel Ab | Chiral adsorbents and their preparation as well as compounds on which the adsorbents are based and their preparation |
| DE4341524C2 (en) * | 1993-12-06 | 1997-01-16 | Gluesenkamp Karl Heinz Dr | Process for immobilizing biomolecules and affinity ligands on polymeric supports |
| US5691152A (en) * | 1995-11-09 | 1997-11-25 | E. R. Squibb & Sons, Inc. | Stable avidin composition |
| SE9700768D0 (en) * | 1997-03-04 | 1997-03-04 | Pharmacia Biotech Ab | Procedure for introducing functionality |
-
1999
- 1999-10-14 AT AT99970668T patent/ATE340192T1/en not_active IP Right Cessation
- 1999-10-14 DE DE69933310T patent/DE69933310T2/en not_active Expired - Fee Related
- 1999-10-14 ES ES99970668T patent/ES2272099T3/en not_active Expired - Lifetime
- 1999-10-14 US US09/807,463 patent/US6656876B1/en not_active Expired - Fee Related
- 1999-10-14 CA CA002346871A patent/CA2346871A1/en not_active Abandoned
- 1999-10-14 WO PCT/SE1999/001861 patent/WO2000023478A1/en not_active Ceased
- 1999-10-14 EP EP99970668A patent/EP1137669B1/en not_active Expired - Lifetime
- 1999-10-14 AU AU14263/00A patent/AU772324B2/en not_active Ceased
- 1999-10-14 JP JP2000577203A patent/JP2002527526A/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| DE69933310T2 (en) | 2007-05-10 |
| DE69933310D1 (en) | 2006-11-02 |
| ES2272099T3 (en) | 2007-04-16 |
| CA2346871A1 (en) | 2000-04-27 |
| WO2000023478A1 (en) | 2000-04-27 |
| AU1426300A (en) | 2000-05-08 |
| ATE340192T1 (en) | 2006-10-15 |
| EP1137669A1 (en) | 2001-10-04 |
| JP2002527526A (en) | 2002-08-27 |
| AU772324B2 (en) | 2004-04-22 |
| US6656876B1 (en) | 2003-12-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5092992A (en) | Polyethyleneimine matrixes for affinity chromatography | |
| AU772324B2 (en) | Squaric acid activated carrier usable for immobilisation of compounds containingamine groups | |
| US5405766A (en) | Immobilization of biologically active protein on a support with a 7-18 carbon spacer and a bifunctional phospholipid | |
| US4722906A (en) | Binding reagents and methods | |
| US3836433A (en) | Fixation of nitrogenous materials | |
| US4175073A (en) | Reactive derivatives of HS-group-containing polymers | |
| ES2326834T3 (en) | MARKING OF OLIGOSACARIDS IN THE SOLID PHASE: A TECHNIQUE FOR THE HANDLING OF IMMOBILIZED CARBOHYDRATES. | |
| JPS6261600B2 (en) | ||
| EP0154315B1 (en) | Improved diazonium affinity matrixes | |
| US6602692B1 (en) | Method for immobilizing biomolecules and affinity ligands on polymer carriers | |
| JPS6027517B2 (en) | Method for immobilizing proteins by polymerizing on the spot | |
| EP0403700B1 (en) | Polyethyleneimine matrixes for affinity chromatography | |
| US4828996A (en) | Materials and method for immobilizing biologically active substances | |
| US5395856A (en) | HPLC avidin monomer affinity resin | |
| CA2108608A1 (en) | Method of attaching dialdehyde starch to a surface and products produced by that method | |
| Messing et al. | Covalent coupling of alkaline bacillus subtilis protease to controlledpore silica with a new simplified coupling technique | |
| AU583060B2 (en) | Sulphuryl chloride/polyamide derivatives | |
| EP0184361A2 (en) | Method of activating polymeric carrier | |
| Simonian et al. | Immobilization and Surface Chemistry | |
| CA1316858C (en) | Method and device for attachment of biologically useful materials to a solid phase | |
| JPH0634633A (en) | Hen's egg antibody fixation carrier and its production | |
| Grover et al. | Affinity chromatography of β-hydroxybutyrate dehydrogenase on NAD and hydrophobic chain derivatives of sepharose | |
| JPH07308575A (en) | Functional material fixing agent | |
| JPH02226070A (en) | Method for determining glycoprotein | |
| RU1838409C (en) | Immobilized adenylate cyclase of plague microbe |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| 17P | Request for examination filed |
Effective date: 20010425 |
|
| AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
| RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: AMERSHAM BIOSCIENCES AB |
|
| RTI1 | Title (correction) |
Free format text: STORAGE-STABLE COMPOSITION COMPRISING SQUARIC ACID ACTIVATED CARRIER USABLE FOR IMMOBILISATION OF COMPOUNDS CONTAINING AMINE GROUPS |
|
| RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: GE HEALTHCARE BIO-SCIENCES AB |
|
| GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
| GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
| GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
| AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT;WARNING: LAPSES OF ITALIAN PATENTS WITH EFFECTIVE DATE BEFORE 2007 MAY HAVE OCCURRED AT ANY TIME BEFORE 2007. THE CORRECT EFFECTIVE DATE MAY BE DIFFERENT FROM THE ONE RECORDED. Effective date: 20060920 Ref country code: FI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20060920 Ref country code: BE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20060920 Ref country code: AT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20060920 |
|
| REG | Reference to a national code |
Ref country code: GB Ref legal event code: FG4D |
|
| RIN1 | Information on inventor provided before grant (corrected) |
Inventor name: ABERG, PER-MIKAEL |
|
| REG | Reference to a national code |
Ref country code: CH Ref legal event code: EP |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20061016 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MC Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20061031 |
|
| REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D |
|
| REF | Corresponds to: |
Ref document number: 69933310 Country of ref document: DE Date of ref document: 20061102 Kind code of ref document: P |
|
| REG | Reference to a national code |
Ref country code: SE Ref legal event code: TRGR |
|
| REG | Reference to a national code |
Ref country code: CH Ref legal event code: NV Representative=s name: ISLER & PEDRAZZINI AG |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: DK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20061220 |
|
| REG | Reference to a national code |
Ref country code: SE Ref legal event code: RPOT |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: PT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20070312 |
|
| REG | Reference to a national code |
Ref country code: ES Ref legal event code: FG2A Ref document number: 2272099 Country of ref document: ES Kind code of ref document: T3 |
|
| EN | Fr: translation not filed | ||
| PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
| REG | Reference to a national code |
Ref country code: CH Ref legal event code: PCAR Free format text: ISLER & PEDRAZZINI AG;POSTFACH 1772;8027 ZUERICH (CH) |
|
| 26N | No opposition filed |
Effective date: 20070621 |
|
| ET | Fr: translation filed | ||
| REG | Reference to a national code |
Ref country code: FR Ref legal event code: EERR Free format text: CORRECTION DE BOPI 07/20 - BREVETS EUROPEENS DONT LA TRADUCTION N A PAS ETE REMISE A L INPI. IL Y A LIEU DE SUPPRIMER : LA MENTION DE LA NON REMISE. LA REMISE DE LA TRADUCTION EST PUBLIEE DANS LE PRESENT BOPI. |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: NL Payment date: 20071024 Year of fee payment: 9 Ref country code: ES Payment date: 20071026 Year of fee payment: 9 Ref country code: DE Payment date: 20071130 Year of fee payment: 9 |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: CH Payment date: 20071030 Year of fee payment: 9 Ref country code: IT Payment date: 20071026 Year of fee payment: 9 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20061221 |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: GB Payment date: 20071029 Year of fee payment: 9 Ref country code: FR Payment date: 20071017 Year of fee payment: 9 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20061014 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: CY Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20060920 |
|
| REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
| GBPC | Gb: european patent ceased through non-payment of renewal fee |
Effective date: 20081014 |
|
| NLV4 | Nl: lapsed or anulled due to non-payment of the annual fee |
Effective date: 20090501 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: NL Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20090501 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20081014 Ref country code: DE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20090501 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LI Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20081031 Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20081031 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GB Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20081014 |
|
| REG | Reference to a national code |
Ref country code: ES Ref legal event code: FD2A Effective date: 20081015 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: ES Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20081015 |
|
| REG | Reference to a national code |
Ref country code: FR Ref legal event code: ST Effective date: 20110708 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: FR Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20081031 |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: SE Payment date: 20111027 Year of fee payment: 13 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20121015 |


